"This is the outcome and regulatory direction the peptide industry has needed, and it provides a path toward smart oversight instead of unregulated ambiguity," said Maximilian Martin, Co-Founder and CEO of Enhanced
Journal of Lipid Research 1986 27:114-20
Gastroenterology 2008 Reported that the tripeptide KPV was taken up via PepT1 and reduced markers of inflammation in cell and mouse models
A counteracting agent may be the stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, MW 1419, an anti-ulcer peptide per-orally active (12-15) that may also affect many central disturbances (16-23), efficient in inflammatory bowel disease trials (PL 14736) (24, 25) and various wound treatment (26-28), no toxicity reported (12, 13, 24, 25)) which showed various hepatoprotective effects (29-31)
Slows cellular aging, helps to strengthen bones, and prevents age-related cognitive decline